Violation Tracker Individual Record
Company:
Avanir Pharmaceuticals
Current Parent Company:
Otsuka Pharmaceutical
Penalty:
$115,874,895
Year:
2019
Date:
September 26, 2019
Offense Group:
government-contracting-related offenses
Primary Offense:
False Claims Act and related
Secondary Offense:
kickbacks and bribery
Violation Description:
Avanir Pharmaceuticals agreed to pay $103 million to resolve civil False Claims Act allegations ($95.972 million to the federal government and $7 million to the states) and $12.8 million to resolve criminal kickback allegations in a case involving payments to physicians to induce prescriptions of its drug Nuedexta.
Level of Government:
federal
Action Type:
agency action
Agency:
Justice Department Civil Division
Civil or Criminal Case:
civil and criminal
Prosecution Agreement:
deferred prosecution agreement
HQ Country of Parent:
Japan
Ownership Structure of Parent:
publicly traded
Major Industry of Parent:
pharmaceuticals
Specific Industry of Parent:
pharmaceuticals
Source of Data:
https://www.justice.gov/opa/pr/pharmaceutical-company-targeting-elderly-victims-admits-paying-kickbacks-resolves-related
Source Notes:
If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Parent company note:
Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.
